RecruitingNCT04923854

Phenotypic Exploration of Autism Spectrum Disorders Retrospective and Prospective Data


Sponsor

Assistance Publique - Hôpitaux de Paris

Enrollment

1,500 participants

Start Date

Jul 1, 2021

Study Type

OBSERVATIONAL

Conditions

Summary

Autism Spectrum Disorders (ASD) are a heterogeneous group of severe developmental abnormalities of the nervous system characterized by deficits in social interaction and verbal and nonverbal communication affecting approximately 1% of the general population. In 5-40% of cases, genetic factors are identified as the cause of these disorders. Despite this unique definition and the advancement of techniques, ASD is still a clinically and genetically heterogeneous condition, as several hundred genes have been identified to date. Primary Objective and Endpoint Primary Objective: Exploration of phenotypic heterogeneity in patients with ASD. Primary endpoint: * Routine Care Clinical Investigation Criteria. * Scores on assessment scales,


Eligibility

Min Age: 1 YearMax Age: 18 Years

Inclusion Criteria1

  • child (age <18 years) with Autism Spectrum DisorderAutism Spectrum Disorder

Exclusion Criteria1

  • \-

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERNo intervention

No intervention


Locations(1)

Hôpital Robert Debré

Paris, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04923854


Related Trials